Tectonic Therapeutic (NASDAQ:TECX) reported quarterly losses of $(1.02) per share which beat the analyst consensus estimate of $(1.05) by 2.86 percent. This is a 15 percent increase over losses of $(1.20) per share from the same period last year.
Tectonic Therapeutic (NASDAQ:TECX) reported quarterly losses of $(1.02) per share which beat the analyst consensus estimate of $(1.05) by 2.86 percent. This is a 15 percent increase over losses of $(1.20) per share from the same period last year.
Comments